Company Amyris, Inc.

AMRS

US03236M2008

Specialty Chemicals

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Specialty Chemicals

Delayed OTC Markets Other stock markets 10:59:36 2024-05-07 am EDT			5-day change	1st Jan Change
0.002 ^USD	0.00%		-60.00%	-20.00%

May. 07	Han Kieftenbeld to leave as Chief Financial Officer of Amyris, Inc	CI
May. 07	Kathy L. Fortmann to Join Amyris, Inc. as Member of the Board of Directors	CI

Amyris, Inc. is a synthetic biotechnology company. The component of the Company is derived from marketing and selling Clean Beauty, Personal Care, and Health & Wellness consumer products through its direct-to-consumer e-commerce platforms and a growing network of retail partners. The Companyâs sustainable ingredients are sold in bulk to industrial leaders who serve Flavor & Fragrance (F&F), Nutrition, Food & Beverage, and Clean Beauty & Personal Care end markets. The ingredients and consumer products it produces by its Lab-to-Market technology platform. The Company leverages machine learning, robotics, and artificial intelligence, which enables its technology platform to rapidly bring new market at commercial scale. The Lab-to-Market technology platform utilizes optimized and automated molecular biology, analytical, and process development tools combined with machine learning algorithms and statistical models to transform the way microbes metabolize sugars.

Number of employees: 1,598

Managers	Title	Age	Since
Sunil Chandran CTO	Chief Tech/Sci/R&D Officer	-	05-12-31
Sola Biu SAM	Sales & Marketing	-	-
Doris Choi LAW	General Counsel	46	20-11-30
Annie Tsong PRN	Corporate Officer/Principal	-	20-12-31
Francisco Costa PRN	Corporate Officer/Principal	-	-
Oreste Cesco Fieschi PRN	Corporate Officer/Principal	-	19-02-10
Christine Ofori HRO	Human Resources Officer	-	-
Anne Myong PRN	Corporate Officer/Principal	56	-
Charles Kraft PRN	Corporate Officer/Principal	-	12-10-08
Philip Gund PRN	Corporate Officer/Principal	62	23-08-08

Members of the board	Title	Age	Since
John Doerr BRD	Director/Board Member	72	06-04-30
J. White BRD	Director/Board Member	56	23-08-28
Ryan Panchadsaram BRD	Director/Board Member	39	21-08-09

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	369,385,614	351,230,619 ( 95.09 %)	0	95.09 %

Name	Equities	%	Valuation
DANUBE AG 4.521 %	16,701,210	4.521 %	167 012 $
Eduardo Alvarez 0.1658 %	612,546	0.1658 %	6 125 $
John Melo 0.1380 %	509,856	0.1380 %	5 099 $
Andbank Wealth Management SGIIC SAU 0.1145 %	423,052	0.1145 %	4 231 $
Elizabeth Dreyer 0.0338 %	125,000	0.0338 %	1 250 $
James McCann 0.0264 %	97,400	0.0264 %	974 $
Lisa Qi 0.0217 %	80,000	0.0217 %	800 $
KURARAY CO., LTD 0.0170 %	62,894	0.0170 %	629 $
Mercer Global Investments Europe Ltd. 0.0164 %	60,545	0.0164 %	605 $
James Caird, Inc. 0.0101 %	37,450	0.0101 %	375 $

Amyris, Inc.

5885 Hollis Street Suite 100

94608, Emeryville

+510 450 0761

http://www.amyris.com

Basic Materials

Specialty Chemicals

Other Specialty Chemicals

	1st Jan change	Capi.
AMYRIS, INC.	-20.00%	745K
ECOLAB INC.	+17.73%	66.69B
SIKA AG	+1.61%	49.2B
GIVAUDAN SA	+16.33%	41.24B
FUJIFILM HOLDINGS CORPORATION	+18.68%	25.89B
EMS-CHEMIE HOLDING AG	+12.78%	19.81B
POSCO FUTURE M CO., LTD.	-21.87%	15.86B
ALBEMARLE CORPORATION	-10.29%	15.23B
SYMRISE AG	+2.32%	15.35B
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-22.30%	13.36B

Other Specialty Chemicals